UCLA researchers have developed a revolutionary microscope.
Read more
Build Networks, Not Bots
Posted in business, robotics/AI
Bots are only as good as their under pinning legacy infrastructure/ networks. Glad to see this article and someone speaking again for investors outside SV.
Bots hit the mark on every pattern Silicon Valley loves. But for investors and entrepreneurs — and executives outside of San Francisco trying to figure out what this bot business is all about — it’s worth taking a step back and looking at this frenzy with fresh eyes and a bigger picture.
Simple interactions between people — making a connection, following and messaging — when captured in a digital network of people who know each other already personally, professionally or by reputation, have created a handful of extremely valuable networks where three billion people today spend the majority of their time.
Facebook pages are like the once-vibrant amusement park that got knocked down for condos.
Again; many problems with AI & IoT all ties back to the infrastructure of things. Focus on fast tracking QC and an interim solution (pre-QC) such as a mix of Nvidia’s GPU, blockchain for financial transactions, etc. to improve the infrastructure and Net then investors will begin to pay more attention to AI, etc.
After more than 60 years since its conceptual inception — and after too many hype-generating moments — AI is yet again making its presence felt in mainstream media.
Following a recent WEF report, many perceive AI as a threat to our jobs, while others even go so far to assert that it poses a real threat to humanity itself.
What is clear for the time being is that there are many questions that still remain unanswered: Can we actually create conscious machines that have the ability to think and feel? What we do we mean by the word conscious in the first place? What is the accurate definition of intelligence? And what are the implications of combining the Internet of Things (IoT) with intelligence?
We’re not there yet. First step will be BMIs which last week’s announcement of the 1st successful human BMI enabling a paralyzed man to use his hands again. Once we perfect BMI plus bio computing as well as other nano technologies we can then say we’re in the age of real HCI and Singularity.
Read more
Bioquark, Inc., (http://www.bioquark.com) a company focused on the development of novel biologics for complex regeneration and disease reversion, and Revita Life Sciences, (http://revitalife.co.in) a biotechnology company focused on translational therapeutic applications of autologous stem cells, have announced that they have received IRB approval for a study focusing on a novel combinatorial approach to clinical intervention in the state of brain death in humans.
This first trial, within the portfolio of Bioquark’s Reanima Project (http://www.reanima.tech) is entitled “Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury” (https://clinicaltrials.gov/ct2/show/NCT02742857?term=bioquark&rank=1), will enroll an initial 20 subjects, and be conducted at Anupam Hospital in Rudrapur, Uttarakhand India.
“We are very excited about the approval of our protocol,” said Ira S. Pastor, CEO, Bioquark Inc. “With the convergence of the disciplines of regenerative biology, cognitive neuroscience, and clinical resuscitation, we are poised to delve into an area of scientific understanding previously inaccessible with existing technologies.”
Death is defined as the termination of all biological functions that sustain a living organism. Brain death, the complete and irreversible loss of brain function (including involuntary activity necessary to sustain life) as defined in the 1968 report of the Ad Hoc Committee of the Harvard Medical School, is the legal definition of human death in most countries around the world. Either directly through trauma, or indirectly through secondary disease indications, brain death is the final pathological state that over 60 million people globally transfer through each year.
While human beings lack substantial regenerative capabilities in the CNS, many non-human species, such as amphibians, planarians, and certain fish, can repair, regenerate and remodel substantial portions of their brain and brain stem even after critical life-threatening trauma.
Additionally, recent studies on complex brain regeneration in these organisms, have highlighted unique findings in relation to the storage of memories following destruction of the entire brain, which may have wide ranging implications for our understanding of consciousness and the stability of memory persistence.
“Through our study, we will gain unique insights into the state of human brain death, which will have important connections to future therapeutic development for other severe disorders of consciousness, such as coma, and the vegetative and minimally conscious states, as well as a range of degenerative CNS conditions, including Alzheimer’s and Parkinson’s disease,” said Dr. Sergei Paylian, Founder, President, and Chief Science Officer of Bioquark Inc.
Over the years, clinical science has focused heavily on preventing such life and death transitions and made some initial progress with suspended animation technologies, such as therapeutic hypothermia. However, once humans transition through the brain death window, currently defined by the medical establishment as “irreversible”, they are technically no longer alive, despite the fact that human bodies can still circulate blood, digest food, excrete waste, balance hormones, grow, sexually mature, heal wounds, spike a fever, and gestate and deliver a baby. It is even acknowledged by thought leaders that recently brain dead humans still may have residual blood flow and electrical nests of activity in their brains, just not enough to allow for an integrated functioning of the organism as a whole.
“We look forward to working closely with Bioquark Inc. on this cutting edge clinical initiative,” said Dr. Himanshu Bansal, Managing Director of Revita Life Sciences.
About Bioquark, Inc.
Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.
About Revita Life Sciences
Revita Life Sciences is a biotechnology company focused on the development of stem cell therapies that target areas of significant unmet medical need. Revita is led by Dr. Himanshu Bansal MD, PhD. who has spent over two decades developing novel MRI based classifications of spinal cord injuries as well as comprehensive treatment protocols with autologous tissues including bone marrow stem cells, dural nerve grafts, nasal olfactory tissues, and omental transposition.
That’s fine with me…
As long as it doesn’t plan on having us for desert. (not until it turns red, gets fat, and burns our planet alive, at least)
A Super-Earth may have formed in our Solar System’s earlier days, and then been destroyed by the Sun.
Very nice; Silicon based Quantum Laser has been achieved. Imagine what this does for ISPs and other communications. smile
A team of researchers from across the country, led by Alexander Spott, University of California, Santa Barbara, USA, have built the first quantum cascade laser on silicon. The advance may have applications that span from chemical bond spectroscopy and gas sensing, to astronomy and free-space communications.
Integrating lasers directly on silicon chips is challenging, but it is much more efficient and compact than coupling external laser light to the chips. The indirect bandgap of silicon makes it difficult to build a laser out of silicon, but diode lasers can be built with III-V materials such as InP or GaAs. By directly bonding an III-V layer on top of the silicon wafer and then using the III-V layers to generate gain for the laser, this same group has integrated a multiple quantum well laser on silicon that operates at 2 µm. Limitations in diode lasers prevent going to longer wavelengths where there are many more applications, so the group turned their attention to using quantum cascade lasers instead.
Building a quantum cascade laser on silicon was a challenging task made more difficult by the fact that silicon dioxide becomes heavily absorptive at longer wavelengths in the mid-infrared.
Read more
Quantum physics has a reputation for being mysterious and mathematically challenging. That makes it all the more surprising that a new technique to detect quantum behaviour relies on a familiar tool: a “zip” program you might have installed on your computer.
“We found a new way to see a difference between the quantum universe and a classical one, using nothing more complex than a compression program,” says Dagomir Kaszlikowski, a Principal Investigator at the Centre for Quantum Technologies (CQT).
Dag worked with other researchers from CQT and collaborators at the Jagiellonian University and Adam Mickiewicz University in Poland to show that compression software, applied to experimental data, can reveal when a system crosses the boundary of our classical picture of the Universe into the quantum realm. The work is published in the March issue of New Journal of Physics (“Probing the quantum–classical boundary with compression software”).
Read more